JP2025507749A5 - - Google Patents

Info

Publication number
JP2025507749A5
JP2025507749A5 JP2024550753A JP2024550753A JP2025507749A5 JP 2025507749 A5 JP2025507749 A5 JP 2025507749A5 JP 2024550753 A JP2024550753 A JP 2024550753A JP 2024550753 A JP2024550753 A JP 2024550753A JP 2025507749 A5 JP2025507749 A5 JP 2025507749A5
Authority
JP
Japan
Application number
JP2024550753A
Other languages
Japanese (ja)
Other versions
JP2025507749A (ja
JPWO2023164696A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063353 external-priority patent/WO2023164696A2/en
Publication of JP2025507749A publication Critical patent/JP2025507749A/ja
Publication of JP2025507749A5 publication Critical patent/JP2025507749A5/ja
Publication of JPWO2023164696A5 publication Critical patent/JPWO2023164696A5/ja
Pending legal-status Critical Current

Links

JP2024550753A 2022-02-28 2023-02-27 プリオン発現のRNAi剤 Pending JP2025507749A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263314800P 2022-02-28 2022-02-28
US63/314,800 2022-02-28
PCT/US2023/063353 WO2023164696A2 (en) 2022-02-28 2023-02-27 Rnai agents of prion expression

Publications (3)

Publication Number Publication Date
JP2025507749A JP2025507749A (ja) 2025-03-21
JP2025507749A5 true JP2025507749A5 (https=) 2026-03-10
JPWO2023164696A5 JPWO2023164696A5 (https=) 2026-03-10

Family

ID=87766801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024550753A Pending JP2025507749A (ja) 2022-02-28 2023-02-27 プリオン発現のRNAi剤

Country Status (4)

Country Link
US (1) US20260028623A1 (https=)
EP (1) EP4486892A2 (https=)
JP (1) JP2025507749A (https=)
WO (1) WO2023164696A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202103794QA (en) 2018-11-21 2021-05-28 Ionis Pharmaceuticals Inc Compounds and methods for reducing prion expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
SG11202103794QA (en) * 2018-11-21 2021-05-28 Ionis Pharmaceuticals Inc Compounds and methods for reducing prion expression

Similar Documents

Publication Publication Date Title
JP2025507749A5 (https=)
CL2025003587A1 (es) Nuevos dispositivos de drenaje y su uso.
BR102023005164A2 (https=)
BR102023000289A2 (https=)
BR202022009269U2 (https=)
BY13153U (https=)
CN307049198S (https=)
CN307049607S (https=)
CN307049606S (https=)
CN307049503S (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13172U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
BY13152U (https=)
BY13159U (https=)
CN307045681S (https=)
BY13157U (https=)
BY13156U (https=)
BY13155U (https=)
BY13165U (https=)